Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive profiling of clinically approved kinase inhibitors reveals mutation-specific inhibitors and opportunities for drug repurposing.

Nature biotechnology·2026
Same author

Intellectual disability risk gene RFX4 regulates cortical neurogenesis by restraining neuronal differentiation.

bioRxiv : the preprint server for biology·2026
Same author

A systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomas.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Beyond genomics: 3D microtumor assays for rapid, clinically relevant functional drug testing.

Oncogene·2025
Same author

Pressurized photobonding for 3D-printed inertial and droplet microfluidics.

Lab on a chip·2025
Same author

Transcriptional Rewiring of BET Inhibitor Treated Ewing Sarcoma Cells Augments their Dependency on Focal Adhesion Kinase.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jan 17, 2026

Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation
16:20

Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation

Published on: July 2, 2018

19.3K

BIOPRINTING OF MICRODISSECTED TUMOR "CUBOIDS" IN HYDROGELS.

Anjul M Bansal1, Lisa F Horowitz1, Marcus Yeung2

  • 1Department of Bioengineering, University of Washington, Seattle, USA.

Biorxiv : the Preprint Server for Biology
|September 18, 2025
PubMed
Summary
This summary is machine-generated.

Precise bioprinting immobilizes microdissected tumor tissues (cuboids) in hydrogels for advanced cancer drug testing and protein analysis. This method enhances microtissue applications in drug discovery and personalized medicine.

Keywords:
BioprintingCancerHydrogelsTumoroids

More Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

764
Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs
10:19

Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs

Published on: August 8, 2022

2.4K

Related Experiment Videos

Last Updated: Jan 17, 2026

Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation
16:20

Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation

Published on: July 2, 2018

19.3K
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

764
Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs
10:19

Ceramic Omnidirectional Bioprinting in Cell-Laden Suspensions for the Generation of Bone Analogs

Published on: August 8, 2022

2.4K

Area of Science:

  • Oncology
  • Biotechnology
  • Bioprinting

Background:

  • Microscale tumor models (e.g., cuboids) preserve the tumor microenvironment (TME) for preclinical research.
  • Current methods struggle with precise microtissue placement, especially within hydrogels.

Purpose of the Study:

  • To develop a bioprinting strategy for precise placement and immobilization of cuboid microtissues in hydrogels.
  • To demonstrate the utility of this method for cancer drug testing and protein profiling.

Main Methods:

  • Utilized a commercial bioprinter to create hydrogel dots containing cuboids.
  • Immobilized cuboids within hydrogel matrices on Transwell inserts or microplates.
  • Applied the method to mouse tumor models.

Main Results:

  • Successfully demonstrated precise placement and immobilization of cuboids in hydrogel.
  • Validated the approach for cancer drug testing and protein profiling applications.
  • Showcased the potential for integrating cuboids with sensors or microfluidic devices.

Conclusions:

  • Bioprinting offers a robust solution for precise microtissue handling in hydrogels.
  • This automated approach enhances the utility of cuboids for drug discovery and personalized medicine.
  • Facilitates advanced applications of microtissues in various biomedical research areas.